Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response

被引:71
|
作者
von Locquenghien, Michelle [1 ]
Rozalen, Catalina [1 ]
Celia-Terrassa, Toni [1 ]
机构
[1] IMIM Hosp Mar Med Res Inst, Canc Res Program, Barcelona, Spain
来源
JOURNAL OF CLINICAL INVESTIGATION | 2021年 / 131卷 / 01期
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; TOLL-LIKE RECEPTORS; IFN-GAMMA; TUMOR-CELLS; DOWN-REGULATION; IMMUNE CHECKPOINTS; BONE METASTASIS; STEM-CELLS; E-CADHERIN; T-CELLS;
D O I
10.1172/JCI143296
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Interferons (IFNs) are pleiotropic cytokines critical for regulation of epithelial cell functions and for immune system regulation. In cancer, IFNs contribute to tumor-intrinsic and-extrinsic mechanisms that determine the quality of antitumor immunity and response to immunotherapy. In this Review, we focus on the different types of tumor IFN sensitivity that determine dynamic tumor-immune interactions and their coevolution during cancer progression and metastasis. We extend the discussion to new evidence supporting immunotherapy-mediated immunoediting and the dual opposing roles of IFNs that lead to immune checkpoint blockade response or resistance. Understanding the intricate dynamic responses to IFN will lead to novel immunotherapeutic strategies to circumvent protumorigenic effects of IFN while exploiting IFNmediated antitumor immunity.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] OMIC signatures to understand cancer immunosurveillance and immunoediting: Melanoma and immune cells interplay in immunotherapy
    Leon-Letelier, Ricardo A.
    Bonifaz, Laura C.
    Fuentes-Panana, Ezequiel M.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2019, 105 (05) : 915 - 933
  • [42] Innate Cancer Immunoediting
    Bald, Tobias
    Smyth, Mark J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (04) : 745 - 747
  • [43] Deconstructing Cancer Immunoediting
    Schreiber, Robert D.
    CYTOKINE, 2011, 56 (01) : 101 - 101
  • [44] Immunoediting finally proves in humans Genetics to help immunotherapy
    Fumet, Jean David
    Ghiringhelli, Francois
    M S-MEDECINE SCIENCES, 2019, 35 (8-9): : 629 - 631
  • [45] HLA-A2 antigen status predicts metastasis and response to immunotherapy in gastric cancer
    Ogoshi, K
    Tajima, T
    Mitomi, T
    Makuuchi, H
    Tsuji, K
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 45 (01) : 53 - 59
  • [46] HLA-A2 Antigen status predicts metastasis and response to immunotherapy in gastric cancer
    Kyoji Ogoshi
    Tomoo Tajima
    Toshi Mitomi
    Hiroyasu Makuuchi
    Kimiyoshi Tsuji
    Cancer Immunology, Immunotherapy, 1997, 45 : 53 - 59
  • [47] CXCR2 Inhibition Suppresses Metastasis and Improves the Response to Immunotherapy in Pancreatic Cancer
    Steele, Colin
    Karim, Saadia
    Leach, Josh
    Bailey, Peter
    Biankin, Andrew
    Nibbs, Rob
    Barry, Simon
    Sansom, Owen
    Morton, Jen
    CANCER RESEARCH, 2016, 76
  • [48] Cancer Immunoediting in Malignant Glioma
    Dunn, Gavin P.
    Fecci, Peter E.
    Curry, William T.
    NEUROSURGERY, 2012, 71 (02) : 201 - 222
  • [49] Interferon-γ and cancer immunoediting
    Gavin P. Dunn
    Hiroaki Ikeda
    Allen T. Bruce
    Catherine Koebel
    Ravi Uppaluri
    Jack Bui
    Ruby Chan
    Mark Diamond
    J. Michael White
    Kathleen C. F. Sheehan
    Robert D. Schreiber
    Immunologic Research, 2005, 32 : 231 - 245
  • [50] Interferon-γ and cancer immunoediting
    Dunn, GP
    Ikeda, H
    T Bruce, A
    Koebel, C
    Uppaluri, R
    Bui, J
    Chan, R
    Diamond, M
    White, JM
    Sheehan, KCF
    Schreiber, RD
    IMMUNOLOGIC RESEARCH, 2005, 32 (1-3) : 231 - 245